Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Tasquinimod by Active Biotech for Post-Polycythemia Vera Myelofibrosis (PPV-MF): Likelihood of Approval
Tasquinimod is under clinical development by Active Biotech and currently in Phase II for Post-Polycythemia Vera Myelofibrosis (PPV-MF). According to...
Tasquinimod by Active Biotech for Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis): Likelihood of Approval
Tasquinimod is under clinical development by Active Biotech and currently in Phase II for Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis). According...
Tasquinimod by Active Biotech for Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF): Likelihood of Approval
Tasquinimod is under clinical development by Active Biotech and currently in Phase II for Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF). According...